These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 20140240)

  • 1. Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease.
    Morgan NV; Morris MR; Cangul H; Gleeson D; Straatman-Iwanowska A; Davies N; Keenan S; Pasha S; Rahman F; Gentle D; Vreeswijk MP; Devilee P; Knowles MA; Ceylaner S; Trembath RC; Dalence C; Kismet E; Köseoğlu V; Rossbach HC; Gissen P; Tannahill D; Maher ER
    PLoS Genet; 2010 Feb; 6(2):e1000833. PubMed ID: 20140240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic intrafamilial variability including H syndrome and Rosai-Dorfman disease associated with the same c.1088G > A mutation in the SLC29A3 gene.
    Chouk H; Ben Rejeb M; Boussofara L; Elmabrouk H; Ghariani N; Sriha B; Saad A; H'Mida D; Denguezli M
    Hum Genomics; 2021 Oct; 15(1):63. PubMed ID: 34657628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of H syndrome showing immunophenotye similarities to Rosai-Dorfman disease.
    Avitan-Hersh E; Mandel H; Indelman M; Bar-Joseph G; Zlotogorski A; Bergman R
    Am J Dermatopathol; 2011 Feb; 33(1):47-51. PubMed ID: 21178579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Egyptian family with H syndrome due to a novel mutation in SLC29A3 illustrating overlapping features with pigmented hypertrichotic dermatosis with insulin-dependent diabetes and Faisalabad histiocytosis.
    Elbarbary NS; Tjora E; Molnes J; Lie BA; Habib MA; Salem MA; Njølstad PR
    Pediatr Diabetes; 2013 Sep; 14(6):466-72. PubMed ID: 22989030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emperipolesis: an additional common histopathologic finding in H syndrome and Rosai-Dorfman disease.
    Colmenero I; Molho-Pessach V; Torrelo A; Zlotogorski A; Requena L
    Am J Dermatopathol; 2012 May; 34(3):315-20. PubMed ID: 22356918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equilibrative nucleotide transporter ENT3 (SLC29A3): A unique transporter for inherited disorders and cancers.
    Ma H; Qu J; Liao Y; Liu L; Yan M; Wei Y; Xu W; Luo J; Dai Y; Pang Z; Qu Q
    Exp Cell Res; 2024 Jan; 434(2):113892. PubMed ID: 38104646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive hearing loss associated with a unique cervical node due to a homozygous SLC29A3 mutation: a very mild phenotype.
    Jonard L; Couloigner V; Pierrot S; Louha M; Gherbi S; Denoyelle F; Marlin S
    Eur J Med Genet; 2012 Jan; 55(1):56-8. PubMed ID: 21888995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLC29A3 mutation in a patient with syndromic diabetes with features of pigmented hypertrichotic dermatosis with insulin-dependent diabetes, H syndrome and Faisalabad histiocytosis.
    de Jesus J; Imane Z; Senée V; Romero S; Guillausseau PJ; Balafrej A; Julier C
    Diabetes Metab; 2013 May; 39(3):281-5. PubMed ID: 23623699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H syndrome: the first 79 patients.
    Molho-Pessach V; Ramot Y; Camille F; Doviner V; Babay S; Luis SJ; Broshtilova V; Zlotogorski A
    J Am Acad Dermatol; 2014 Jan; 70(1):80-8. PubMed ID: 24172204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of two novel mutations in SLC29A3 encoding an equilibrative nucleoside transporter (hENT3) in two distinct Syrian families with H syndrome: expression studies of SLC29A3 (hENT3) in human skin.
    Farooq M; Moustafa RM; Fujimoto A; Fujikawa H; Abbas O; Kibbi AG; Kurban M; Shimomura Y
    Dermatology; 2012; 224(3):277-84. PubMed ID: 22653152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human equilibrative nucleoside transporter-3 (hENT3) spectrum disorder mutations impair nucleoside transport, protein localization, and stability.
    Kang N; Jun AH; Bhutia YD; Kannan N; Unadkat JD; Govindarajan R
    J Biol Chem; 2010 Sep; 285(36):28343-52. PubMed ID: 20595384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mild form of SLC29A3 disorder: a frameshift deletion leads to the paradoxical translation of an otherwise noncoding mRNA splice variant.
    Bolze A; Abhyankar A; Grant AV; Patel B; Yadav R; Byun M; Caillez D; Emile JF; Pastor-Anglada M; Abel L; Puel A; Govindarajan R; de Pontual L; Casanova JL
    PLoS One; 2012; 7(1):e29708. PubMed ID: 22238637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosai-Dorfman Disease and Exocrine Pancreatic Insufficiency in a Patient With a Germline SLC29A3 Mutation.
    Blatt J; Parekh P; Powell BC; Fedoriw Y; Reddy I; Montgomery ND
    J Pediatr Hematol Oncol; 2021 Jul; 43(5):e689-e691. PubMed ID: 32769566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation in the SLC29A3 gene: a new cause of a monogenic, autoinflammatory condition.
    Melki I; Lambot K; Jonard L; Couloigner V; Quartier P; Neven B; Bader-Meunier B
    Pediatrics; 2013 Apr; 131(4):e1308-13. PubMed ID: 23530176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tocilizumab for the Treatment of SLC29A3 Mutation Positive PHID Syndrome.
    Rafiq NK; Hussain K; Brogan PA
    Pediatrics; 2017 Nov; 140(5):. PubMed ID: 29079714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLC29A3 gene is mutated in pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome and interacts with the insulin signaling pathway.
    Cliffe ST; Kramer JM; Hussain K; Robben JH; de Jong EK; de Brouwer AP; Nibbeling E; Kamsteeg EJ; Wong M; Prendiville J; James C; Padidela R; Becknell C; van Bokhoven H; Deen PM; Hennekam RC; Lindeman R; Schenck A; Roscioli T; Buckley MF
    Hum Mol Genet; 2009 Jun; 18(12):2257-65. PubMed ID: 19336477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel 3' untranslated region mutation in the SLC29A3 gene associated with pigmentary hypertrichosis and non-autoimmune insulin-dependent diabetes mellitus syndrome.
    Riachi M; Bas F; Darendeliler F; Hussain K
    Pediatr Diabetes; 2019 Jun; 20(4):474-481. PubMed ID: 30821020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel homozygous SLC29A3 mutations among two unrelated Egyptian families with spectral features of H-syndrome.
    Al-Haggar M; Salem N; Wahba Y; Ahmad N; Jonard L; Abdel-Hady D; El-Hawary A; El-Sharkawy A; Eid AR; El-Hawary A
    Pediatr Diabetes; 2015 Jun; 16(4):305-16. PubMed ID: 24894595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel start-loss mutation of the SLC29A3 gene in a consanguineous family with H syndrome: clinical characteristics, in silico analysis and literature review.
    Rezaie N; Mansour Samaei N; Ghorbani A; Gholipour N; Vosough S; Rafigh M; Amini A
    BMC Med Genomics; 2024 Jul; 17(1):178. PubMed ID: 38965556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the clinical spectrum of SLC29A3 gene defects.
    Spiegel R; Cliffe ST; Buckley MF; Crow YJ; Urquhart J; Horovitz Y; Tenenbaum-Rakover Y; Newman WG; Donnai D; Shalev SA
    Eur J Med Genet; 2010; 53(5):309-13. PubMed ID: 20619369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.